Boston Financial Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $4.11M | Buy |
5,320
+300
| +6% | +$248K | 0.12% | 108 |
|
|
2024
Q3 | $4.45M | Buy |
5,020
+13
| +0.3% | +$11.7K | 0.13% | 108 |
|
|
2024
Q2 | $4.53M | Sell |
5,007
-37
| -0.7% | -$29.6K | 0.14% | 101 |
|
|
2024
Q1 | $3.92M | Sell |
5,044
-22
| -0.4% | -$15.7K | 0.12% | 110 |
|
|
2023
Q4 | $2.95M | Sell |
5,066
-252
| -5% | -$147K | 0.1% | 119 |
|
|
2023
Q3 | $2.86M | Sell |
5,318
-35
| -0.7% | -$18K | 0.11% | 119 |
|
|
2023
Q2 | $2.51M | Sell |
5,353
-641
| -11% | -$269K | 0.09% | 125 |
|
|
2023
Q1 | $2.06M | Sell |
5,994
-63
| -1% | -$21.2K | 0.08% | 137 |
|
|
2022
Q4 | $2.22M | Sell |
6,057
-234
| -4% | -$83K | 0.09% | 129 |
|
|
2022
Q3 | $2.03M | Buy |
6,291
+152
| +2% | +$48.2K | 0.09% | 124 |
|
|
2022
Q2 | $1.99M | Sell |
6,139
-30
| -0.5% | -$9.01K | 0.09% | 121 |
|
|
2022
Q1 | $1.77M | Buy |
6,169
+271
| +5% | +$69.7K | 0.07% | 130 |
|
|
2021
Q4 | $1.63M | Buy |
5,898
+65
| +1% | +$16.5K | 0.06% | 125 |
|
|
2021
Q3 | $1.35M | Buy |
5,833
+1,175
| +25% | +$290K | 0.05% | 129 |
|
|
2021
Q2 | $1.07M | Buy |
4,658
+30
| +0.6% | +$6.03K | 0.04% | 132 |
|
|
2021
Q1 | $865K | Buy |
4,628
+184
| +4% | +$36K | 0.04% | 133 |
|
|
2020
Q4 | $750K | Hold |
4,444
| – | – | 0.03% | 141 |
|
|
2020
Q3 | $658K | Hold |
4,444
| – | – | 0.03% | 145 |
|
|
2020
Q2 | $730K | Hold |
4,444
| – | – | 0.04% | 137 |
|
|
2020
Q1 | $616K | Buy |
4,444
+75
| +2% | +$10.3K | 0.04% | 143 |
|
|
2019
Q4 | $574K | Sell |
4,369
-216
| -5% | -$25K | 0.03% | 160 |
|
|
2019
Q3 | $513K | Sell |
4,585
-8
| -0.2% | -$891 | 0.03% | 176 |
|
|
2019
Q2 | $509K | Sell |
4,593
-362
| -7% | -$42.6K | 0.03% | 178 |
|
|
2019
Q1 | $643K | Sell |
4,955
-754
| -13% | -$91.7K | 0.04% | 161 |
|
|
2018
Q4 | $661K | Buy |
5,709
+954
| +20% | +$107K | 0.05% | 163 |
|
|
2018
Q3 | $510K | Sell |
4,755
-84
| -2% | -$8.4K | 0.03% | 210 |
|
|
2018
Q2 | $413K | Sell |
4,839
-70
| -1% | -$5.75K | 0.03% | 197 |
|
|
2018
Q1 | $380K | Hold |
4,909
| – | – | 0.03% | 206 |
|
|
2017
Q4 | $415K | Sell |
4,909
-353
| -7% | -$30K | 0.03% | 206 |
|
|
2017
Q3 | $450K | Buy |
5,262
+496
| +10% | +$40.7K | 0.03% | 202 |
|
|
2017
Q2 | $392K | Buy |
4,766
+961
| +25% | +$78.4K | 0.03% | 214 |
|
|
2017
Q1 | $320K | Sell |
3,805
-550
| -13% | -$44.1K | 0.02% | 226 |
|
|
2016
Q4 | $320K | Buy |
+4,355
| New | +$324K | 0.03% | 229 |
|
|
2015
Q3 | – | Sell |
-3,356
| Closed | -$280K | – | 196 |
|
|
2015
Q2 | $280K | Hold |
3,356
| – | – | 0.04% | 186 |
|
|
2015
Q1 | $244K | Buy |
3,356
+150
| +5% | +$10.7K | 0.03% | 193 |
|
|
2014
Q4 | $221K | Hold |
3,206
| – | – | 0.03% | 193 |
|
|
2014
Q3 | $208K | Buy |
+3,206
| New | +$203K | 0.03% | 200 |
|
|
2014
Q2 | – | Sell |
-4,527
| Closed | -$266K | – | 205 |
|
|
2014
Q1 | $266K | Sell |
4,527
-425
| -9% | -$23.7K | 0.04% | 184 |
|
|
2013
Q4 | $253K | Sell |
4,952
-151
| -3% | -$7.56K | 0.03% | 190 |
|
|
2013
Q3 | $257K | Buy |
5,103
+25
| +0.5% | +$1.31K | 0.04% | 187 |
|
|
2013
Q2 | $249K | Buy |
+5,078
| New | +$276K | 0.04% | 190 |
|
Other funds holding LLY
Boston Financial Management's LLY Position: Q4 2024 in Review
Boston Financial Management increased its Eli Lilly (LLY) stake by 6% in Q4 2024, buying an estimated $248K and bringing the position to 5,320 shares worth $4.11M. The position accounts for 0.12% of the portfolio, ranked #108.
Boston Financial Management first reported a position in LLY in Q2 2013 and has held it in 41 quarters since. The position peaked at $4.53M in Q2 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q4 2024.
- Boston Financial Management held 5,320 shares of Eli Lilly worth $4.11M as of Q4 2024.
- Boston Financial Management bought 300 Eli Lilly shares in Q4 2024, an estimated $248K.
- Eli Lilly made up 0.12% of Boston Financial Management's portfolio in Q4 2024, its #108 holding.
- Boston Financial Management first reported a position in Eli Lilly in Q2 2013 and has held it in 41 quarters since.
- Boston Financial Management's Eli Lilly position peaked at $4.53M in Q2 2024.
- 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.
Based on Boston Financial Management's 13F filing for Q4 2024, filed 3 Feb 2025.